SANTINI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 988
AS - Asia 556
EU - Europa 388
SA - Sud America 168
AF - Africa 50
Totale 2.150
Nazione #
US - Stati Uniti d'America 963
SG - Singapore 216
BR - Brasile 135
VN - Vietnam 107
CN - Cina 90
IT - Italia 86
RU - Federazione Russa 78
SE - Svezia 51
IE - Irlanda 46
HK - Hong Kong 45
BD - Bangladesh 27
CI - Costa d'Avorio 27
DE - Germania 27
FR - Francia 26
IN - India 25
UA - Ucraina 23
GB - Regno Unito 17
CA - Canada 14
FI - Finlandia 13
IQ - Iraq 8
MX - Messico 8
AR - Argentina 7
ID - Indonesia 7
VE - Venezuela 7
ZA - Sudafrica 7
CO - Colombia 5
DZ - Algeria 5
EC - Ecuador 5
MY - Malesia 5
NL - Olanda 5
TR - Turchia 5
MA - Marocco 4
PL - Polonia 4
AT - Austria 3
BO - Bolivia 3
CL - Cile 3
JP - Giappone 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
TN - Tunisia 3
AZ - Azerbaigian 2
DK - Danimarca 2
KR - Corea 2
LT - Lituania 2
SV - El Salvador 2
TH - Thailandia 2
BF - Burkina Faso 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PK - Pakistan 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 2.150
Città #
Ashburn 258
Singapore 127
Chandler 86
San Jose 67
Dublin 46
Fairfield 44
Hong Kong 44
New York 32
Ho Chi Minh City 31
Dallas 30
Boardman 28
Hanoi 28
The Dalles 28
Abidjan 27
Beijing 25
Jacksonville 25
Houston 21
Lawrence 20
Princeton 20
Lauterbourg 17
Turin 16
Los Angeles 15
Moscow 13
San Diego 13
Seattle 13
Milan 12
Munich 12
Wilmington 12
Washington 11
Chennai 9
Woodbridge 9
São Paulo 8
Turku 8
Buffalo 7
Cambridge 7
London 7
Council Bluffs 6
Rio de Janeiro 6
Ann Arbor 5
Da Nang 5
Montreal 5
San Mateo 5
Santa Clara 5
Baghdad 4
Boston 4
Denver 4
Haiphong 4
Helsinki 4
Johannesburg 4
Macerata 4
Naples 4
Orem 4
Warsaw 4
Columbus 3
Curitiba 3
Frankfurt am Main 3
Hefei 3
La Paz 3
Mexico City 3
Mumbai 3
Paris 3
Porto Alegre 3
Quito 3
San Francisco 3
Tokyo 3
Toronto 3
Aparecida de Goiânia 2
Aracaju 2
Atlanta 2
Barranquilla 2
Belo Horizonte 2
Bragança Paulista 2
Brooklyn 2
Bến Tre 2
Casablanca 2
Chicago 2
Contagem 2
Culiacán 2
Eelde 2
Guangzhou 2
Guaratinguetá 2
Hải Dương 2
Jaú 2
Joinville 2
La Plata 2
Lagoa Santa 2
Manchester 2
Marche 2
Miano 2
Mountain View 2
Nasiriyah 2
Ninh Bình 2
Oklahoma City 2
Oran 2
Palermo 2
Phoenix 2
Pune 2
Quảng Ngãi 2
Quận Ba 2
Redwood City 2
Totale 1.360
Nome #
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients 166
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 139
Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR) 135
Outcomes of advanced gastric cancer patients treated with at least three lines of systemic chemotherapy 132
Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? 120
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: There is a sense in antisense? 115
Role of STAT3 pathway in genitourinary tumors 113
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study 112
Prognostic vs predictive molecular biomarkers in colorectal cancer: Is KRAS and BRAF wild type status required for anti-EGFR therapy? 109
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? [Ann Oncol, 23, 9, (2012) (2313-2318)] doi: 10.1093/annonc/mdr623 103
A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients 101
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting 98
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 93
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 88
Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: A literature-based meta-analysis 88
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 86
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target? 84
Germline copy number variation in the YTHDC2 gene: Does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 84
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: A retrospective analysis 83
Driver mutations and differential sensitivity to targeted therapies: A new approach to the treatment of lung adenocarcinoma 75
Predicting efficacy and toxicity in the era of targeted therapy: Focus on anti-EGFR and anti-VEGF molecules 75
Totale 2.199
Categoria #
all - tutte 12.177
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.177


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/2022134 4 5 4 0 1 3 0 4 35 16 41 21
2022/2023273 20 28 34 10 15 33 1 12 68 1 43 8
2023/2024196 26 5 19 24 29 59 2 8 0 1 14 9
2024/2025432 29 24 5 10 23 55 86 20 69 16 36 59
2025/20261.023 95 47 47 74 129 62 172 101 86 74 89 47
Totale 2.199